The use of oral contraceptives as a prevention of recurrent premenstrual psychosis

Psychiatry Research

Volumn 170, Issue 2-3, 2009, Pages 290-291

  Coromina Sadurni, Marta ^a   Rodie, Judith Usall ^a,b   de Montagut, Laia Miquel ^a   Sánchez Autet, Mònica ^a  

^a Centre de Salut Mental El Prat   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Chlormadinone acetate; Recurrent brief psychotic disorder; Treatment

Indexed keywords

AMISULPRIDE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; DIAZEPAM; HALOPERIDOL; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ADULT; ANXIETY; ARTICLE; CASE REPORT; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; MENSTRUAL CYCLE; PREMENSTRUAL PSYCHOSIS; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; RELAPSE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; CHLORMADINONE ACETATE; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHYNODIOL DIACETATE; FEMALE; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 70449533056     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.02.015     Document Type: Article

References (12)

1. Bäckström T., and Hammarbäck S. Premenstrual syndrome-psychiatric or gynaecological disorder?. Annals of Medicine 23 6 (1991) 625-633
2. Birmingham M.K., Barta A., Solyom L., Lehoux J.G., and Vecsei P. Correlations between mood scores, LH, adrenocortical steroids, and urine volumes in a patient with a history of postpartum depression and monthly psychotic episodes. Endocrine Research 24 3-4 (1998) 595-599
3. Brockington I. Menstrual psicosis. World Psychiatry 4 1 (2005) 9-17
4. Choi S.H., Kang S.B., and Joe S.H. Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosomatic Medicine 63 (2001) 822-829
5. Deuchar N., and Brockington I. Puerperal and menstrual psychoses: the proposal of a unitary etiological hypothesis. Journal of Psychosomatic Obstetrics and Gynaecology 19 (1998) 104-110
6. Felthous A.R., Robinson D.B., and Conroy R.W. Prevention of recurrent menstrual psychosis by an oral contraceptive. American Journal of Psychiatry 137 2 (1980) 245-246
7. Fink G., Sumner B.E., Rosie R., Grace O., and Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state and memory. Cellular and Molecular Neurobiology 16 16 (1996) 325-344
8. Halbreich U., and Kahn L.S. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28 (2003) 1-16
9. Hallonquist J.D., Seeman M.V., Lang M., and Rectot N.A. Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry 33 (1993) 207-209
10. Huber J.C., Heskamp M.L., and Schramm G.A. Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies. Clinical Drug Investigation 28 12 (2008) 783-791
11. Lindamer L.A., Lohr J.B., Harris M.J., and Jeste D.V. Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin 33 2 (1997) 221-228
12. Stein D., Blumensohn R., and Witztum E. International Journal of Psychiatry in Medicine 33 2 (2003) 169-179